A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas

Glioblastoma is the most common malignant brain parenchymal tumor yet remains challenging to treat. The current standard of care—resection and chemoradiation—is limited in part due to the genetic heterogeneity of glioblastoma. Previous studies have identified several tumor genetic biomarkers that ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Evan, Villanueva-Meyer, Javier E., Cha, Soonmee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366666/
https://www.ncbi.nlm.nih.gov/pubmed/32678261
http://dx.doi.org/10.1038/s41598-020-68857-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366666/
https://www.ncbi.nlm.nih.gov/pubmed/32678261
http://dx.doi.org/10.1038/s41598-020-68857-8

Ejemplares similares